Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F02V6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,198
Award facts
- Contract value 100% obligated
- $15,197.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,197.57 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Otezla 30 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 7, 2026, and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor within the federal medical procurement system, particularly for military and veteran healthcare systems. The company competes on a full and open basis for federal contracts and maintains an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains. This specific delivery order for Otezla—a prescription medication used in dermatological and rheumatological treatments—demonstrates the company's role in supplying specialized brand-name pharmaceuticals to support Defense Health Agency and other federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F02V6?
SPE2DR26F02V6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F02V6 worth?
The government has obligated $15,198 on SPE2DR26F02V6.
Is contract SPE2DR26F02V6 an order under another contract?
Yes. SPE2DR26F02V6 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F02V6 competed?
The extent of competition for SPE2DR26F02V6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award